Application Accepted for Inhaled Pulmonary Fibrosis Treatment
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
Two people in Southeastern Pennsylvania have died after being infected with measles—the state's first measles-related deaths since 1991 and the first reported in the United States this year.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.
New research suggests that nearly 10% of patients hospitalized with pneumonia in certain regions test positive for Coccidioides (valley fever).
Research highlights significant delays in the transition from emergency care to inpatient management for admitted patients.
Specific circular DNA features found in blood and tissue could help clinicians identify patients at high risk for recurrence after surgery.
Secondhand tobacco smoke increased sleep interruptions in pediatric patients, even when traditional apnea measures remain unchanged.